As said before, this secretion of IFNγ allows T cell proliferation as well as an increased expression of PD-L1 on AML cells, and for now, a possible approach to preventing this adaptive resistance and diminishing the risk of relapse could be to associate immune checkpoint inhibition with chemotherapy [144,145]. The gene discussed is CD274; the disease is acute myeloid leukemia.